激活的组织内存T细胞 (CD8+CD103+CD39+) 独特地预测左侧"免疫热"结肠直肠癌的存活率

Shahd Talhouni1,2, Wakkas Fadhil3, Nigel P Mongan4,5

  • 1Cancer Immunology Group, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, United Kingdom.

PubMed
概括

激活的瘤特异性T细胞 (TRM) 是比单独的CD8T细胞更好的结直肠癌存活率预测器. 左侧瘤需要TRM分析以获得准确的预后和治疗,与右侧瘤不同.